Factor Xa inhibitor, Rivaroxaban, Purity ≥98%

Cat. No.: X24-09-YM130

Factor Xa inhibitor, Rivaroxaban, Purity ≥98%

Synonym: 366789-02-8; BAY 59-7939; Xarelto; 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide; Factor Xa inhibitor

  • MDL: MFCD11974010
  • CAS Number: 366789-02-8
  • Compound CID: 9875401
Product Size
5 mg; 10 mg; 20 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Rivaroxaban, soluble in DMSO and insoluble in water and ethanol, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting factor Xa. The molecular weight of the compound is 435.9, and its molecular formula is C19H18ClN3O5S. It targets the Factor Xa (Cell-free assay) and Prothrombinase (Cell-free assay).
Molecular Weight
435.9
Molecular Formula
C19H18ClN3O5S
Targets
Factor Xa (Cell-free assay)
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO: 83 mg/mL (190.41 mM); Water: insoluble; Ethanol: insoluble; In vivo: 0.5% methylcellulose + 0.2% Tween 80, 4 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
Rivaroxaban can be studied extensively for its potential therapeutic applications in the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke in patients with non-valvular atrial fibrillation (AF).
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0